Adimmune is a vaccine manufacturer that makes influenza, Japanese encephalitis, and tetanus vaccines, with a portfolio including trivalent and quadrivalent influenza vaccines, a monovalent H1N1 vaccine, Japanese encephalitis vaccine, tetanus toxoid, and purified tuberculin. It manufactures on egg-based and cell-culture platforms at PIC/S GMP-certified plants.
Adimmune is the sole producer of influenza vaccines in Taiwan holding both EU GMP and US FDA certificates. The firm backs Sanofi Pasteur's efforts to commercialize a recombinant protein quadrivalent influenza vaccine in the United States, and its regulatory affairs team has worked with authorities in the United States, European Union, Thailand, Japan, China, and Taiwan. These relationships make its buyers international pharmaceutical partners and regulators in the United States, European Union, Thailand, Japan, and China.